{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:52:13Z","timestamp":1791355933007,"version":"4.3.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0137596","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T17:51:22Z","timestamp":1441302682000},"page":"e0137596","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013"],"prefix":"10.1371","volume":"10","author":[{"given":"Kristin K.","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salimah","family":"Shariff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hramiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/dc06-2000","article-title":"Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994\u20132004","volume":"30","author":"W Rathmann","year":"2007","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0895-4356(97)00024-3","article-title":"Rates of hypoglycemia in users of sulfonylureas","volume":"50","author":"T Van Staa","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1185\/03007995.2011.554532","article-title":"Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus","volume":"27","author":"J Doucet","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/dom.12102","article-title":"Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: A prospective, double-blind, randomized, 1-year study","volume":"15","author":"J Rosenstock","year":"2013","journal-title":"Diabetes, Obes Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"HC Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"A Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"ref7","unstructured":"Statistics Canada website. Statistics Canada: Population by sex and age group, by province and territory (Number, both sexes). 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/demo31a-eng.htm\" xlink:type=\"simple\">http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/demo31a-eng.htm<\/ext-link>"},{"key":"ref8","article-title":"Aging in Ontario: An ICES Chartbook of Health Service Use by Older Adults [Internet]","author":"S Bronskill","year":"2010"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"E Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"JE Hux","year":"2002","journal-title":"Diabetes Care"},{"key":"ref11","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"AR Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"R Turner","year":"1998","journal-title":"Lancet"},{"key":"ref13","article-title":"Canadian Diabetes Association Guidelines: Pharmacological Management of Type 2 Diabetes [Internet]","author":"W Harper","year":"2013"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11845-013-1011-1","article-title":"Prescribing of antidiabetic therapies in Ireland: 10-Year trends 2003\u20132012","volume":"183","author":"NL Zaharan","year":"2014","journal-title":"Ir J Med Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pds.1802","article-title":"Trends in the prescription of anti-diabetic medications in the United Kingdom: A population-based analysis","volume":"18","author":"KB Filion","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diabres.2011.05.004","article-title":"Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy\u2019s Lombardy Region: a large population-based study","volume":"93","author":"M Baviera","year":"2011","journal-title":"Diabetes Res Clin Pract [Internet]"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/dc13-2289","article-title":"Use of antidiabetic drugs in the U.S., 2003\u20132012","volume":"37","author":"C Hampp","year":"2014","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"302.e1","DOI":"10.1016\/j.amjmed.2011.07.033","article-title":"Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications","author":"NR Desai","year":"2012","journal-title":"The American Journal of Medicine"},{"key":"ref19","article-title":"Canadian Diabetes Association Guidelines: Diabetes in the Elderly [Internet]","author":"G Meinelly","year":"2013"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"SE Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"SE Nissen","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"PD Home","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"ref23","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.298.22.2634","article-title":"Thiazolidinediones and cardiovascular outcomes in older patients with diabetes","volume":"298","author":"LL Lipscombe","year":"2007","journal-title":"JAMA [Internet]"},{"key":"ref24","article-title":"The rise and fall of the thiazolidinediones: Impact of clinical evidence publication and formulary change on the prescription incidence of thiazolidinediones","volume":"20","author":"S Hashim","year":"2013","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/dme.12214","article-title":"Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006","volume":"30","author":"PD Foster","year":"2013","journal-title":"Diabet Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"AM Lincoff","year":"2007","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc09-1834","article-title":"Changes in Glitazone Use Among Office- Based Physicians in the U. S., 2003\u20132009","volume":"33","author":"A Cohen","year":"2010","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomised controlled trial","volume":"366","author":"JA Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1463-1326.2002.00211.x","article-title":"Simultaneous glyburide\/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes","volume":"4","author":"AJ Garber","year":"2002","journal-title":"Diabetes, Obes Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1463-1326.2005.00541.x","article-title":"Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (&gt;60 years): The Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study","volume":"8","author":"J Rosenstock","year":"2006","journal-title":"Diabetes, Obes Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1463-1326.2006.00659.x","article-title":"Initial treatment with rosiglitazone\/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes","volume":"8","author":"J Rosenstock","year":"2006","journal-title":"Diabetes, Obes Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National Trends in US Hospital Admissions for Hyperglycemia and Hypoglycemia Among Medicare Beneficiaries, 1999 to 2011","volume":"174","author":"KJ Lipska","year":"2014","journal-title":"JAMA Intern Med [Internet]"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2337\/diacare.28.5.1045","article-title":"Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada","volume":"28","author":"GL Booth","year":"2005","journal-title":"Diabetes Care"},{"key":"ref34","first-page":"251","article-title":"Rates of Complications and Mortality in Older Patients With Diabetes Mellitus: The Diabetes and Aging Study","volume":"60637","author":"ES Huang","year":"2013","journal-title":"JAMA Intern Med [Internet]"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0137596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:06:12Z","timestamp":1540271172000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0137596"}},"subtitle":[],"editor":[{"given":"Marta Letizia","family":"Hribal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0137596","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}